TCIM
ZBH icon

TIAA CREF Investment Management’s Zimmer Biomet ZBH Stock Holding History

TIAA CREF Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$301M Sell
2,428,490
-254,222
-9% -$28.9M 0.21% 98
2018
Q4 		$270M Sell
2,682,712
-88,007
-3% -$9.9M 0.21% 96
2018
Q3 		$354M Buy
2,770,719
+245,328
+10% +$29.2M 0.23% 93
2018
Q2 		$273M Buy
2,525,391
+284,017
+13% +$30.9M 0.18% 122
2018
Q1 		$237M Buy
2,241,374
+1,075,411
+92% +$125M 0.16% 132
2017
Q4 		$137M Buy
1,165,963
+419,278
+56% +$47.4M 0.09% 233
2017
Q3 		$84.9M Buy
746,685
+19,809
+3% +$2.29M 0.06% 313
2017
Q2 		$90.6M Sell
726,876
-5,866
-0.8% -$695K 0.06% 304
2017
Q1 		$86.9M Sell
732,742
-135,731
-16% -$15.4M 0.06% 318
2016
Q4 		$87M Sell
868,473
-100,593
-10% -$10.8M 0.06% 310
2016
Q3 		$122K Sell
969,066
-322,773
-25% -$39.9M 0.08% 248
2016
Q2 		$151M Buy
1,291,839
+177,826
+16% +$20.1M 0.12% 185
2016
Q1 		$115M Buy
1,114,013
+612,426
+122% +$59.2M 0.09% 234
2015
Q4 		$50M Sell
501,587
-10,785
-2% -$1.06M 0.04% 448
2015
Q3 		$46.7M Sell
512,372
-27,701
-5% -$2.78M 0.04% 461
2015
Q2 		$57.3M Sell
540,073
-307,254
-36% -$34M 0.04% 442
2015
Q1 		$96.7M Sell
847,327
-33,467
-4% -$3.82M 0.07% 314
2014
Q4 		$97M Buy
880,794
+30,975
+4% +$3.27M 0.07% 314
2014
Q3 		$83M Buy
849,819
+99,102
+13% +$9.75M 0.06% 332
2014
Q2 		$75.7M Sell
750,717
-180,303
-19% -$17.6M 0.05% 372
2014
Q1 		$85.5M Sell
931,020
-224,454
-19% -$20.7M 0.06% 341
2013
Q4 		$105M Sell
1,155,474
-170,829
-13% -$14.8M 0.08% 284
2013
Q3 		$106M Buy
1,326,303
+310,562
+31% +$24.4M 0.08% 262
2013
Q2 		$73.9M Buy
+1,015,741
New +$75.9M 0.06% 341

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Investment Management's ZBH Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Zimmer Biomet (ZBH) stake by 9.5% in Q1 2019, selling an estimated $28.9M and leaving 2,428,490 shares worth $301M. The position accounts for 0.21% of the portfolio, ranked #98.

TIAA CREF Investment Management first reported a position in ZBH in Q2 2013 and has held it in 24 quarters since. The position peaked at $354M in Q3 2018. 896 funds tracked by Wall St. Rank hold ZBH as of Q1 2019.

  • TIAA CREF Investment Management held 2,428,490 shares of Zimmer Biomet worth $301M as of Q1 2019.
  • TIAA CREF Investment Management sold 254,222 Zimmer Biomet shares in Q1 2019, an estimated $28.9M.
  • Zimmer Biomet made up 0.21% of TIAA CREF Investment Management's portfolio in Q1 2019, its #98 holding.
  • TIAA CREF Investment Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Zimmer Biomet position peaked at $354M in Q3 2018.
  • 896 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.